Sign up
Pharma Capital

Callitas Health enlists advertising team to spread the word about its fertility gel

The biotech will use social media and influencers to promote its fertility-enhancing gel
1531228470_Baby-sitting.jpg
The Ohio-based company develops female sexual health and wellness products

Callitas Health Inc (CSE:LILY, OTCQB:MPHMF, OTCMKTS: MPHMF) is expanding the reach of its fertility gel ToConceive through a new marketing channel.

ToConceive is a fertility-enhancing paraben-free vaginal gel designed to create the right environment for natural conception. The formula has been approved by the US Food and Drug Administration.

READ: Long-term partnership with leading condom-maker LifeStyles brings Callitas Health's products into new global markets

The clinical-stage pharmaceutical company has launched its affiliate network for ToConceive through advertising firm W4 Performance Ad Market.

W4 has previously worked with big-name companies like Netflix Inc (NASDAQ:NFLX) and Groupon Inc (NASDAQ:GRPN).

Through a variety of online advertisements, including newsletters and social media, Callitas hopes to get the word out about to couples about its fertility and female sexual health and wellness products.

BIG PICTURE: Callitas Health Inc has big plans for broad product portfolio

"The network will also allow us to incentivize influencers, thought leaders and bloggers to partner with our current and new products,” said CEO James Thompson in a press statement.

Shares of the Ohio-based biotech were up more than 5% to US$0.16 by Monday’s closing bell.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

View full LILY profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.